The New Clinical Investigation exclusivity: a substantial source of monopoly time for brand drugs
Crossref DOI link: https://doi.org/10.1038/s41587-025-02696-8
Published Online: 2025-06-16
Published Print: 2025-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Feldman, Robin https://orcid.org/0000-0002-3453-134X
Schor, Gideon
Alsaffar, Ramy
Text and Data Mining valid from 2025-06-01
Version of Record valid from 2025-06-01
Article History
First Online: 16 June 2025
Competing interests
: The authors declare no competing interests.